Skip to main content
Chemtai-Mungo-RobertA.Winn-Diversity-Clinical-Trials-Award-Program
Chemtai Mungo

Chemtai Mungo, MD, MPH, FACOG, a member of the Institute for Global Health and Infectious Diseases and assistant professor of Obstetrics and Gynecology has been selected for the “Robert A. Winn Excellence in Clinical Trials: Career Development Award” (Winn CDA), a prestigious two-year national program that trains early-career physicians to design and lead community-centered clinical trials.  The Winn CDA is part of the Robert A. Winn Diversity in Clinical Trials Award Program, a multi-year, $100M+ public–private initiative established by the Bristol Myers Squibb Foundation with partners including Gilead Sciences, Amgen, Genentech, and the American Association of Cancer Research (AACR). The program’s mission is to increase diversity in clinical trials, transform the clinical research landscape, and ensure that treatments are tested, safe, and effective for all patients—especially those in communities that have historically been excluded from research.